# US 2026/0083805 A1 · Composition comprising glycyrrhiza uralensis extract and method and use thereof for skeletal muscle growth in animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083805 A1
- Document ID: US20260083805A1
- Status: Published application
- Kind: A1
- Application number: 18/891,418
- Filed: 2024-09-20
- Published: 2026-03-26
- Earliest claimed: 2024-09-20
- Assignees: Academia Sinica
- Applicants: Academia Sinica
- Inventors: Yu-Chuan LIANG; Bor-Rung OU
- Web page: https://patentgrep.com/patent/US20260083805A1

## CPC

- A61K 36/484: Glycyrrhiza (licorice)
- A23K 10/30: from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms (obtained by microbiological or biochemical processes, e.g. using yeasts or enzymes, A23K10/10)
- A23K 20/111: Aromatic compounds
- A23K 20/121: containing oxygen or sulfur as hetero atom
- A23K 50/30: for swines
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- G01N 33/5061: {Muscle cells}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23K: FODDER
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure provides a phytogenic-containing composition and applications thereof in agriculture. Specifically, the present disclosure relates to a composition comprising Glycyrrhiza uralensis extract, or an active compound isolated from the G. uralensis extract, a method for promoting skeletal muscle growth of animals by utilizing the composition, and use of the composition as a phytogenic feed additive for animals.

## Claims

### Claim 1

A composition comprising Glycyrrhiza uralensis extract or an active compound isolated from the G. uralensis extract.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the G. uralensis extract or the active compound isolated from the G. uralensis extract is present in an amount effective to promote skeletal muscle growth in an animal in need thereof.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the G. uralensis extract is present at a concentration ranging from about 5 μg/mL to about 30 μg/mL.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the G. uralensis extract is present at a concentration ranging from about 6.25 μg/mL to about 25 μg/mL.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the G. uralensis extract is present at a concentration ranging from about 12.5 μg/mL to about 25 μg/mL.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the G. uralensis extract is present at a concentration of about 12.5 μg/mL or about 25 μg/mL.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the active compound isolated from G. uralensis extract in the composition of the present disclosure is selected from the group consisting of gancaonin G, cudraflavone-C and licoisoflavone A.

### Claim 8

A method for promoting skeletal muscle growth in an animal in need thereof, comprising administering to the animal a composition in an animal feed, wherein the composition comprises G. uralensis extract or an active compound isolated from the G. uralensis extract.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the G. uralensis extract is present at a concentration ranging from about 5 μg/mL to about 30 μg/mL.

### Claim 10 (depends on 8)

The method according to claim 8, wherein the G. uralensis extract is present at a concentration ranging from about 6.25 μg/mL to about 25 μg/mL.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the G. uralensis extract is present at a concentration ranging from about 12.5 μg/mL to about 25 μg/mL.

### Claim 12 (depends on 8)

The method according to claim 8, wherein the G. uralensis extract is present at a concentration of about 6.25 μg/mL, about 12.5 μg/mL, or about 25 μg/mL.

### Claim 13 (depends on 8)

The method according to claim 8, wherein the active compound isolated from G. uralensis extract is selected from the group consisting of gancaonin G, cudraflavone-C and licoisoflavone A.

### Claim 14 (depends on 8)

The method according to claim 8, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.01% to about 0.1% by weight of the feed.

### Claim 15 (depends on 8)

The method according to claim 8, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.01% to about 0.05% by weight of the feed.

### Claim 16 (depends on 8)

The method according to claim 8, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.05% to about 0.1% by weight of the feed.

### Claim 17 (depends on 8)

The method according to claim 8, wherein the composition when comprises G. uralensis extract in an amount of about 0.01%, about 0.5%, or 0.1% by weight of the feed.

### Claim 18

Use of a composition comprising G. extract or an active compound isolated from the G. uralensis extract as a feed additive for promoting skeletal muscle growth in an animal in need thereof.

### Claim 19 (depends on 18)

The use according to claim 18, wherein the G. uralensis extract is present at a concentration ranging from about 5 μg/mL to about 30 μg/mL.

### Claim 20 (depends on 18)

The use according to claim 18, wherein the G. uralensis extract is present at a concentration ranging from about 6.25 μg/mL to about 25 μg/mL.

### Claim 21 (depends on 18)

The use according to claim 18, wherein the G. uralensis extract is present at a concentration ranging from about 12.5 μg/mL to about 25 μg/mL.

### Claim 22 (depends on 18)

The use according to claim 18, wherein the G. uralensis extract is present at a concentration of about 6.25 μg/mL, about 12.5 μg/mL, or about 25 μg/mL.

### Claim 23 (depends on 18)

The use according to claim 18, wherein the active compound isolated from G. uralensis extract is selected from the group consisting of gancaonin G, cudraflavone-C and licoisoflavone A.

### Claim 24 (depends on 18)

The use according to claim 18, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.01% to about 0.1% by weight of the feed.

### Claim 25 (depends on 18)

The use according to claim 18, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.01% to about 0.05% by weight of the feed.

### Claim 26 (depends on 18)

The use according to claim 18, wherein the composition when comprises G. uralensis extract in an amount ranging from about 0.05% to about 0.1% by weight of the feed.

### Claim 27 (depends on 18)

The use according to claim 18, wherein the composition when comprises G. uralensis extract in an amount of about 0.01%, about 0.5%, or 0.1% by weight of the feed.

### Claim 28 (depends on 1)

An animal feed additive comprising a composition according to claim 1.

### Claim 29

A screening method for a potential phytogenic in promoting skeletal muscle growth in animals comprises:
(a) preparing a plant extract from a plant or plant part of interest;
(b) preparing the animal cells by transfecting the cells with a plasmid containing a myostatin-luciferase (MSTN-Luc) reporter gene;
(c) treating the transfected animal cells from (b) with the herbal extract from (a) and maintaining the treated cells in a culture medium under a condition sufficient for cell proliferation;
(d) measuring cell proliferation of the treated cells from (c);
(e) measuring the luciferase activity of the treated cells from (c);
(f) comparing the cell proliferation measured in (d) with a vehicle control under the same condition;
(g) comparing the luciferase activity measured in (e) with a control under the same condition; and
(h) determining the plant extract tested as effective phytogenic for promoting skeletal muscle growth by the increased cell proliferation and higher inhibition of luciferase activity exhibited by the cells treated with the plant extract.

### Claim 30 (depends on 29)

The screening method according to claim 29, wherein the animal cells prepared in (b) are rat L8 myoblast cell line.

### Claim 31 (depends on 29)

The screening method according to claim 29, wherein the cell proliferation of the treated cells in (d) is measured by performing MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) colorimetric assay.

### Claim 32 (depends on 31)

The screening method according to claim 31, wherein MTT reagent is added to the treated cells cultivated in a culture medium at 37° C. for 4 h, followed by adding dimethyl sulfoxide (DMSO) to detect optical density at 595 nm.

### Claim 33 (depends on 29)

The screening method according to claim 29, wherein the luciferase activity of the treated cells incubated in a culture medium is measured in (e) after 24 h treatment.
